The Pharma major launches Celevida Maxx nutrition drink for cancer, critical care and COPD patients in India
Pharma major Dr. Reddy’s Laboratories on Tuesday said it is foraying into the hospital nutrition segment in India with a nutrition drink.The product, Celevida Maxx, is a unique addition to its nutrition portfolio and designed to help manage nutritional needs of cancer, critical care and chronic obstructive pulmonary disease (COPD) patients, the Hyderabad-headquartered firm said.“We are pleased to foray into the hospital nutrition segment in India. With Celevida Maxx, we look forward to strengthening our presence in the nutrition segment and continue making a positive impact on patients’ lives,” CEO, Branded Markets (India and Emerging Markets) M.V. Ramana said.Celevida Maxx contains a unique triple action formula of high protein, high omega 3 fatty acids to help tackle the problem of inflammation and Astaxanthin, which is clinically proven to support immunity, a release from Dr. Reddy’s said. The nutrition drink contains vegetarian ingredients, no added sugar and comes in two flavors, Orange and Strawberry.In 2019, Dr. Reddy’s had entered the nutritional market with Celevida, a nutrition drink for diabetes patients.
You have reached your limit for free articles this month.
To get full access, please subscribe.
Already have an account ? Sign in
Show Less Plan
Subscription Benefits Include
Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.
Move smoothly between articles as our pages load instantly.
Enjoy reading as many articles as you wish without any limitations.
A one-stop-shop for seeing the latest updates, and managing your preferences.
A select list of articles that match your interests and tastes.
We brief you on the latest and most important developments, three times a day.
*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.
A letter from the Editor
Dear subscriber,Thank you!Your support for our journalism is invaluable. It’s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.Suresh Nambath